Increased plasma concentrations of vitamin D metabolites and vitamin D binding protein in women using hormonal contraceptives: A cross-sectional study

Nutrients

Volumn 5, Issue 9, 2013, Pages 3470-3480

  Møller, Ulla K ^a   Vid Streym, Susanna ^a   Jensen, Lars T ^b   Mosekilde, Leif ^a   Schoenmakers, Inez ^c   Nigdikar, Shailja ^c   Rejnmark, Lars ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^c MRC HUMAN NUTRITION RESEARCH   (United Kingdom)

Author keywords

1,25 dihydroxyvitamin D; 25Hydroxyvitamin D; Bone mineral density; Bone turnover; Calcitonin; Hormonal contraceptives; Parathyroid hormone; Vitamin D binding protein

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; 25 HYDROXYERGOCALCIFEROL; ALKALINE PHOSPHATASE; CALCITONIN; CALCIUM; CREATININE; ORAL CONTRACEPTIVE AGENT; OSTEOCALCIN; PARATHYROID HORMONE; VITAMIN D BINDING PROTEIN;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; BONE DENSITY; BONE METABOLISM; CALCIUM BLOOD LEVEL; CALCIUM HOMEOSTASIS; CALCIUM METABOLISM; CAUCASIAN; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DRUG RESPONSE; FEMALE; FEMALE CONTRACEPTIVE DEVICE; HORMONE RESPONSE; HUMAN; HUMAN CELL; INTRAUTERINE CONTRACEPTIVE DEVICE; LUMBAR SPINE; PHOSPHATE BLOOD LEVEL; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; SUB DERMAL CONTRACEPTIVE IMPLANT; VAGINA RING; VITAMIN BLOOD LEVEL; WINTER;

ADULT; BONE DENSITY; CALCITONIN; CALCIUM; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVES, ORAL, HORMONAL; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; PARATHYROID HORMONE; SEASONS; VITAMIN D; VITAMIN D-BINDING PROTEIN;

EID: 84884273083     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu5093470     Document Type: Article

References (29)

1. Holick, M.F. Vitamin D status: Measurement, interpretation, and clinical application. Ann. Epidemiol. 2009, 19, 73-78.
2. Mosekilde, L. Vitamin D and the elderly. Clin. Endocrinol. 2005, 62, 265-281.
3. Holick, M.F. Resurrection of vitamin D deficiency and rickets. J. Clin. Investig. 2006, 116, 2062-2072.
4. Hewison, M.; Burke, F.; Evans, K.N.; Lammas, D.A.; Sansom, D.M.; Liu, P.; Modlin, R.L.; Adams, J.S. Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease. J. Steroid Biochem. Mol. Biol. 2007, 103, 316-321.
5. Bikle, D.D.; Gee, E.; Halloran, B.; Kowalski, M.A.; Ryzen, E.; Haddad, J.G. Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J. Clin. Endocrinol. Metab. 1986, 63, 954-959.
6. Bikle, D.D.; Siiteri, P.K.; Ryzen, E.; Haddad, J.G. Serum protein binding of 1,25-dihydroxyvitamin D: A reevaluation by direct measurement of free metabolite levels. J. Clin.Endocrinol. Metab. 1985, 61, 969-975.
7. Holick, M.F.; Chen, T.C. Vitamin D deficiency: A worldwide problem with health consequences. Am. J. Clin. Nutr. 2008, 87, 1080S-1086S.
8. Chan, J.; Jaceldo-Siegl, K.; Fraser, G.E. Determinants of serum 25 hydroxyvitamin D levels in a nationwide cohort of blacks and non-Hispanic whites. Cancer Causes Control 2010, 21, 501-511.
9. Nesby-O'Dell, S.; Scanlon, K.S.; Cogswell, M.E.; Gillespie, C.; Hollis, B.W.; Looker, A.C.; Allen, C.; Doughertly, C.; Gunter, E.W.; Bowman, B.A. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: Third National Health and Nutrition Examination Survey, 1988-1994. Am. J. Clin. Nutr. 2002, 76, 187-192.
10. Bouillon, R.; van Assche, F.A.; van Baelen, H.; Heyns, W.; de Moor, P. Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1,25-dihydroxyvitamin D3 concentration. J. Clin. Investig. 1981, 67, 589-596.
11. Haddad, J.G.,; Walgate, J. Radioimmunoassay of the binding protein for vitamin D and its metabolites in human serum: Concentrations in normal subjects and patients with disorders of mineral homeostasis. J. Clin. Investig. 1976, 58, 1217-1222.
12. Møller, U.; Streym, S.; Heickendorff, L.; Mosekilde, L.; Rejnmark, L. Effects of 25OHD concentrations on chances of pregnancy and pregnancy outcomes. A cohort study in healthy Danish women. Eur. J. Clin. Nutr. 2012, 66, 862-868.
13. Cross, N.A.; Hillman, L.S.; Allen, S.H.; Krause, G.F. Changes in bone mineral density and markers of bone remodeling during lactation and postweaning in women consuming high amounts of calcium. J. Bone Miner. Res. 1995, 10, 1312-1320.
14. Ritchie, L.D.; Fung, E.B.; Halloran, B.P.; Turnlund, J.R.; van Loan, M.D.; Cann, C.E.; King, J.C. A longitudinal study of calcium homeostasis during human pregnancy and lactation and after resumption of menses. Am. J. Clin. Nutr. 1998, 67, 693-701.
15. Aarskog, D.; Aksnes, L.; Markestad, T.; Rodland, O. Effect of estrogen on vitamin D metabolism in tall girls. J. Clin. Endocrinol. Metab. 1983, 57, 1155-1158.
16. Harris, S.S.; Dawson-Hughes, B. The association of oral contraceptive use with plasma25-hydroxyvitamin D levels. J. Am. Coll. Nutr. 1998, 17, 282-284.
17. Gagnon, C.; Baillargeon, J.P.; Desmarais, G.; Fink, G.D. Prevalence and predictors of vitamin D insufficiency in women of reproductive age living in northern latitude. Eur. J. Endocrinol. 2010, 163, 819-824.
18. Van Hoof, H.J.; de Sevaux, R.G.; van Baelen, H.; Swinkels, L.M.; Klipping, C.; Ross, H.A.; Sweep, C.G. Relationship between free and total 1,25-dihydroxyvitamin D in conditions of modified binding. Eur. J. Endocrinol. 2001, 144, 391-396.
19. Rejnmark, L.; Lauridsen, A.L.; Brot, C.; Vestergaard, P.; Heickendorff, L.; Nexo, E.; Mosekilde, L. Vitamin D and its binding protein Gc: Long-term variability in peri- and postmenopausal women with and without hormone replacement therapy. Scand. J. Clin. Lab.Investig. 2006, 66, 227-238.
20. Gravholt, C.H.; Leth-Larsen, R.; Lauridsen, A.L.; Thiel, S.; Hansen, T.K.; Holmskov, U.; Naeraa, R.W.; Christiansen, J.S. The effects of GH and hormone replacement therapy on serum concentrations of mannan-binding lectin, surfactant protein D and vitamin D binding protein in Turner syndrome. Eur. J. Endocrinol. 2004, 150, 355-362.
21. Moller, U.K.; vi{eth} Streym, S.; Mosekilde, L.; Rejnmark, L. Changes in bone mineral density and body composition during pregnancy and postpartum. A controlled cohort study. Osteoporos. Int. 2012, 23, 1213-1223.
22. Hermann, A.P.; Thomsen, J.; Vestergaard, P.; Mosekilde, L.; Charles, P. Assessment of calcium intake. A quick method comparerd to a 7 days food diary. Calcif. Tissue Int. 1999, 64, S82.
23. Maunsell, Z.; Wright, D.J.; Rainbow, S.J. Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clin. Chem. 2005, 51, 1683-1690.
24. Hojskov, C.S.; Heickendorff, L.; Moller, H.J. High-throughput liquid-liquid extraction and LCMSMS assay for determination of circulating 25(OH) vitamin D3 and D2 in the routine clinical laboratory. Clin. Chim. Acta 2010, 411, 114-116.
25. Schifter, S. A new highly sensitive radioimmunoassay for human calcitonin useful for physiological studies. Clin. Chim. Acta 1993, 215, 99-109.
26. Mosekilde, L. Vitamin D requirement and setting recommendation levels: Long-term perspectives. Nutr. Rev. 2008, 66, S170-S177.
27. Favus, M. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 6th ed.; Bikle, D.D., Christakos, S., Goldring, S.R., Guise, T.H., Holick, M.F., Jan de Beur, S., Kaplan, F.S., Kleerekoper, M., Langman, C.B., Lian, J.B., et al., Eds.; American Society for Bone and Mineral Research: Washington, DC, USA, 2006; pp. 50-132.
28. Henry, H.L.; Norman, A.W. Vitamin D: Metabolism and biological actions. Annu. Rev. Nutr. 1984, 4, 493-520.
29. Mendel, C.M. The free hormone hypothesis: A physiologically based mathematical model. Endocr. Rev. 1989, 10, 232-274.